Some Benefit to Treating Mild Hypertension to Prevent Stroke, CV Deaths, and Overall Mortality
Am Fam Physician. 2015 Dec 1;92(11):1020.
What are the benefits of treating mild hypertension?
Treating mild hypertension over five years decreases the risk of stroke, cardiovascular (CV) death, and overall mortality in a small proportion of patients. The numbers needed to treat (NNT)—the numbers of patients who need to be treated to prevent one additional outcome from occurring—are below. Pay attention to the confidence intervals (CIs), which tell us the best/worst case possibilities. Also, note that some of these intervals are very large, meaning that we cannot place much confidence in the reported NNT. (Level of Evidence = 1a)
The authors used the literature search results of a previous Cochrane meta-analysis and updated it by searching several databases. They included studies that lasted at least one year and evaluated treatment of grade 1 hypertension (range = 140/90 mm Hg to 159/99 mm Hg) in patients with no previous cardiac disease. They were able to use individual patient data (instead of comparing only the results across studies) for a total of 15,266 patients. The risk of bias in the studies was low. The research included single-drug treatment and stepped-care approaches. Over an average five years of treatment, there was no significant decrease in overall CV events, coronary events, or, predictably, heart failure. The likelihood of a stroke, death due to a CV event, or all-cause mortality was lower with treatment (see below). Overall, 5.6% of patients withdrew from treatment because of adverse effects (number needed to treat to harm = 36; 95% CI, 23 to 75). Other NNTs for the five years (95% CI) included: stroke = 173 (108 to 810); CV death = 95 (55 to 1,188); overall mortality = 99 (66 to 273); heart failure = not significant; and coronary events = not significant.
Study design: Meta-analysis (randomized controlled trials)
Funding source: Government
Setting: Various (meta-analysis)
Reference: Sundström J, Arima H, Jackson R, et al.; Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of blood pressure reduction in mild hypertension: a systematic review and meta-analysis. Ann Intern Med. 2015; 162( 3): 184– 191.
POEMs (patient-oriented evidence that matters) are provided by EssentialEvidence Plus, a point-of-care clinical decision support system published by Wiley-Blackwell. For more information, please see http://www.essentialevidenceplus.com. Copyright Wiley-Blackwell. Used with permission.
For definitions of levels of evidence used in POEMs, see http://www.essentialevidenceplus.com/product/ebm_loe.cfm?show=oxford.
To subscribe to a free podcast of these and other POEMs that appear in AFP,search in iTunes for “POEM of the Week” or go to http://goo.gl/3niWXb.
This series is coordinated by Sumi Sexton, MD, Associate Deputy Editor.
A collection of POEMs published in AFP is available at https://www.aafp.org/afp/poems.
Want to use this article elsewhere? Get Permissions
More in AFP
MOST RECENT ISSUE
Jan 15, 2020
Access the latest issue of American Family Physician